Skip to main content

Peer Review reports

From: Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension

Original Submission
20 Dec 2021 Submitted Original manuscript
12 Jan 2022 Reviewed Reviewer Report
21 Jan 2022 Reviewed Reviewer Report
23 Jan 2022 Reviewed Reviewer Report
14 Feb 2022 Author responded Author comments - Yan-min Yang
Resubmission - Version 2
14 Feb 2022 Submitted Manuscript version 2
18 Feb 2022 Author responded Author comments - Yan-min Yang
Resubmission - Version 3
18 Feb 2022 Submitted Manuscript version 3
28 Feb 2022 Reviewed Reviewer Report
5 Mar 2022 Reviewed Reviewer Report
17 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Mar 2022 Editorially accepted
1 Apr 2022 Article published 10.1186/s12872-022-02580-2

You can find further information about peer review here.

Back to article page